PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2010 | 151 |
| 2011 | 179 |
| 2012 | 282 |
| 2013 | 295 |
| 2014 | 303 |
| 2015 | 269 |
| 2016 | 252 |
| 2017 | 262 |
| 2018 | 297 |
| 2019 | 327 |
| 2020 | 405 |
| 2021 | 366 |
| 2022 | 328 |
| 2023 | 337 |
| 2024 | 386 |
| 2025 | 495 |
| 2026 | 326 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"ACS Med Chem Lett"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins.
- Malarz K, Marforio TD, Gawecki R, Dreszer D, Calvaresi M, Serda M.
- ACS Med Chem Lett. 2026 Aug 3;17(10):2153-2159. doi: 10.1021/acsmedchemlett.6c00282.
- PMCID: PMC13656267
Malarz K, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656267 -
Albumin-Binding Moieties Tune the Pharmacokinetics and Tumor Uptake of 177Lu-Labeled GRPR Radioligands.
- Obeid K, Håkansson EO, Bezverkhniaia E, Skillinghaug B, Rosenström U, Kanellopoulos P, Orlova A, Odell LR.
- ACS Med Chem Lett. 2026 Sep 4;17(10):2211-2218. doi: 10.1021/acsmedchemlett.6c00338.
- PMCID: PMC13656281
Obeid K, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656281 -
Cannabinol β‑O-Glucoside Inhibitors of the Keap1-Nrf2 Interaction: A Novel Therapeutic Strategy for Parkinson's Disease.
- Deshmukh P, Aouti S, Sridhar A, Kommu P, K A, Singh S, Nalli Y, Noor A, Srinivas BMM, Ali A, Padmanabhan B.
- ACS Med Chem Lett. 2026 Sep 1;17(10):2127-2139. doi: 10.1021/acsmedchemlett.6c00156.
- PMCID: PMC13656285
Deshmukh P, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656285 -
Scope and Differences between ACS Medicinal Chemistry Letters and Journal of Medicinal Chemistry.
- Chibale K, Lindsley CW.
- ACS Med Chem Lett. 2026 Oct 8;17(10):2095-2096. doi: 10.1021/acsmedchemlett.6c00476.
- PMCID: PMC13656264
Chibale K, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656264 -
Fluorinated 4‑Methylideneisoxazolidin-5-ones: Synthesis and Apoptosis-Inducing Antiproliferative Activity.
- Li ZH, Han Y, Li YC, Zhang XQ, Kalita SJ, Huang YY.
- ACS Med Chem Lett. 2026 Sep 25;17(10):2219-2229. doi: 10.1021/acsmedchemlett.6c00344.
- PMCID: PMC13656280
Li ZH, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656280 -
Targeting Latent Tuberculosis Using Hypoxia-Activated Prodrugs of Bedaquiline Analogues.
- Kim CG, Hay MP, Anderson RF, Kumara S, Franzblau SG, Cooper CB, Jose J, Choi PJ.
- ACS Med Chem Lett. 2026 Sep 3;17(10):2140-2152. doi: 10.1021/acsmedchemlett.6c00238.
- PMCID: PMC13656266
Kim CG, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656266 -
Novel Compounds as SMARCA2 Inhibitors for Treating Non-Small Cell Lung Cancer.
- Sabnis RW.
- ACS Med Chem Lett. 2026 Sep 26;17(10):2119-2120. doi: 10.1021/acsmedchemlett.6c00489.
- PMCID: PMC13656282
Sabnis RW.ACS Med Chem Lett. 2026.PMCID: PMC13656282 -
Structure-Based Drug Design of Quinoline CYP8B1 Inhibitors for the Potential Treatment of Metabolic Disease.
- McCracken AB, Li D, Caldwell JP, Lankin C, Tagat J, Khan T, Rao A, Zhang T, Caplen MA, Verras A, Orth P, Hruza A, Ho T, Allen S, Elsen NL, Dingley K, Duffy R, Wisniewski T, Murphy B, Castro-Perez J, Wong K, Streckfuss E, Liu J, Tong W, McKittrick B.
- ACS Med Chem Lett. 2026 Sep 16;17(10):2245-2250. doi: 10.1021/acsmedchemlett.6c00387.
- PMCID: PMC13656273
McCracken AB, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656273 -
Synthesis of 1,3-Dihydro-2,1-benzisoxazoles by Intramolecular C-N Coupling: Evaluation as an Indane Bioisostere.
- Beckler TD, Crich D.
- ACS Med Chem Lett. 2026 Sep 27;17(10):2260-2268. doi: 10.1021/acsmedchemlett.6c00429.
- PMCID: PMC13656276
Beckler TD, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656276 -
Antibody Hotspot-Centric de Novo Design of Peptide Inhibitors of Influenza A Virus Membrane Fusion.
- Kadam RU, Juraszek J, Branduardi D, van Ameijde J, Garg D, Vermond J, Jongeneelen M, Tang C, Vogels R, van Dongen MJP, Brandenburg B, Friesen RHE, Wilson IA.
- ACS Med Chem Lett. 2026 Sep 21;17(10):2191-2196. doi: 10.1021/acsmedchemlett.6c00321.
- PMCID: PMC13656271
Kadam RU, et al.ACS Med Chem Lett. 2026.PMCID: PMC13656271